The role of vitamin D in prevention and treatment of infection

Inflammation and Allergy - Drug Targets

Volumn 12, Issue 4, 2013, Pages 239-245

  Gunville, Cameron F ^a   Mourani, Peter M ^a   Ginde, Adit A ^b  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial; Cathelicidin; Immune system; Infection; Inflammation; Vitamin D

Indexed keywords

CALCIFEDIOL; CATHELICIDIN; COLECALCIFEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR;

ANTIMICROBIAL ACTIVITY; ARTICLE; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DISEASE SEVERITY; DRUG EFFICACY; GENETIC POLYMORPHISM; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INFECTION; INFLUENZA A; META ANALYSIS (TOPIC); NONHUMAN; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; TUBERCULOSIS; VIRUS INFECTION; VIRUS REPLICATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTI-INFECTIVE AGENTS; DIETARY SUPPLEMENTS; HUMANS; IMMUNE SYSTEM; INFECTION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84882747595     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/18715281113129990046     Document Type: Article

References (56)

1. Institute of Medicine, Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press 2012. Available at: http://www.nap.edu/catalog.php?record_id=13050.
2. American Academy of Pediatrics. Dietary reference intakes for calcium and vitamin D. Available at: www.pediatrics.org/cgi/doi/10.1542/peds.2012-2590.
3. Holick, M. F. Vitamin D deficiency. N. Engl. J. Med., 2007, 357(3), 266-281.
4. Dixon, B. M.; Barker, T.; McKinnon, T.; Cuomo, J.; Frei, B.; Borregaard, N.; Gombart, A. F. Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res. Notes, 2012, 5, 575.
5. Kempker, J. A.; Martin, G.S. Vitamin D and Sepsis: From Associations to Causal Connections. Inflamm. Allergy Drug Targets, 2013, 12(4), 000.
6. Mora, J. R.; Iwata, M.; von Andrian, U. H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol., 2008, 8(9), 685-698.
7. Hewison, M. An update on vitamin D and human immunity. Clin. Endocrinol. (Oxf.), 2012, 76(3), 315-325.
8. Hansdottir, S.; Monick, M. M.; Hinde, S. L.; Lovan, N.; Look, D. C.; Hunninghake, G. W. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J. Immunol., 2008, 181(10), 7090-7099.
9. Liu, P. T.; Stenger, S.; Li, H.; Wenzel, L.; Tan, B. H.; Krutzik, S. R.; Ochoa, M. T.; Schauber, J.; Wu, K.; Meinken, C.; Kamen, D. L.; Wagner, M.; Bals, R.; Steinmeyer, A.; Zugel, U.; Gallo, R. L.; Eisenberg, D.; Hewison, M.; Hollis, B. W.; Adams, J. S.; Bloom, B. R.; Modlin, R. L. Toll-like receptor triggering of a vitamin Dmediated human antimicrobial response. Science, 2006, 311(5768), 1770-1773.
10. White, J. H. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future. J. Steroid Biochem. Mol. Biol., 2010, 121(1-2), 234-238
11. Yim, S. Dhawan, P. Ragunath, C. Christakos, S. Diamond, G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J. Cyst. Fibros., 2007, 6(6), 403-410.
12. Ramanathan, B. Davis, E. G. Ross, C. R. Blecha, F. Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect., 2002, 4(3), 361-372.
13. van der Does, A. M. Bergman, P. Agerberth, B. Lindbom, L. Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections. J. Leukoc. Biol., 2012, 92(4), 735-742.
14. Barlow, P. G. Svoboda, P. Mackellar, A. Nash, A. A. York, I. A. Pohl, J. Davidson, D. J. Donis, R. O. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One, 2011, 6(10), e25333.
15. Adams, J. S. Hewison, M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab., 2008, 4(2), 80-90.
16. Edfeldt, K. Liu, P. T. Chun, R. Fabri, M. Schenk, M. Wheelwright, M. Keegan, C. Krutzik, S. R. Adams, J. S. Hewison, M. Modlin, R. L. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc. Natl. Acad. Sci. U. S. A., 2010, 107(52), 22593-22598.
17. Kawai, T. Akira, S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med., 2007, 13(11), 460-469.
18. Hansdottir, S. Monick, M. M. Lovan, N. Powers, L. Gerke, A. Hunninghake, G. W. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J. Immunol., 2010, 184(2), 965-974.
19. McNally, P. Coughlan, C. Bergsson, G. Doyle, M. Taggart, C. Adorini, L. Uskokovic, M. R. El-Nazir, B. Murphy, P. Greally, P. Greene, C. M. McElvaney, N. G. Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis. J. Cyst. Fibros., 2011, 10(6), 428-434.
20. Ginde, A. A. Mansbach, J. M. Camargo, C. A, Jr,. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med., 2009, 169(4), 384-390.
21. Laaksi, I. Ruohola, J. P. Tuohimaa, P. Auvinen, A. Haataja, R. Pihlajamaki, H. Ylikomi, T. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am. J. Clin. Nutr., 2007, 86(3), 714-717.
22. Sabetta, J. R. DePetrillo, P. Cipriani, R. J. Smardin, J. Burns, L. A. Landry, M. L. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One, 2010, 5(6), e11088.
23. Quint, J. K. Donaldson, G. C. Wassef, N. Hurst, J. R. Thomas, M. Wedzicha, J. A. 25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease. BMC Pulm. Med., 2012, 12, 28.
24. Rodriguez, M. Daniels, B. Gunawardene, S. Robbins, G. K. High frequency of vitamin D deficiency in ambulatory HIV-Positive patients. AIDS Res. Hum. Retroviruses, 2009, 25(1), 9-14.
25. Villamor, E. A potential role for vitamin D on HIV infection? Nutr. Rev., 2006, 64(5 Pt 1), 226-233.
26. Connor, R. I. Rigby, W. F. 1 alpha,25-dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1. Biochem. Biophys. Res. Commun., 1991, 176(2), 852-859.
27. Ansemant, T. Mahy, S. Piroth, C. Ornetti, P. Ewing, S. Guilland, J. C. Croisier, D. Duvillard, L. Chavanet, P. Maillefert, J. F. Piroth, L. Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients. BMC Infect. Dis., 2013, 13, 7.
28. Matthews, L. R. Ahmed, Y. Wilson, K. L. Griggs, D. D. Danner, O. K. Worsening severity of vitamin D deficiency is associated with increased length of stay, surgical intensive care unit cost, and mortality rate in surgical intensive care unit patients. Am. J. Surg., 2012, 204(1), 37-43.
29. Braun, A. Chang, D. Mahadevappa, K. Gibbons, F. K. Liu, Y. Giovannucci, E. Christopher, K. B. Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit. Care Med., 2011, 39(4), 671-677.
30. Leow, L. Simpson, T. Cursons, R. Karalus, N. Hancox, R. J. Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology, 2011, 16(4), 611-616.
31. Higgins, D. M. Wischmeyer, P. E. Queensland, K. M. Sillau, S. H. Sufit, A. J. Heyland, D. K. Relationship of vitamin D deficiency to clinical outcomes in critically ill patients. JPEN J. Parenter. Enteral Nutr., 2012, 36(6), 713-720.
32. Yamshchikov, A. V. Kurbatova, E. V. Kumari, M. Blumberg, H. M. Ziegler, T. R. Ray, S. M. Tangpricha, V. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am. J. Clin. Nutr., 2010, 92(3), 603-611.
33. Iacob, S. A. Panaitescu, E. Iacob, D. G. Cojocaru, M. The human cathelicidin LL37 peptide has high plasma levels in B and C hepatitis related to viral activity but not to 25-hydroxyvitamin D plasma level. Rom. J. Intern. Med., 2012, 50(3), 217-223.
34. Mansbach, J. M. Piedra, P. A. Borregaard, N. Martineau, A. R. Neuman, M. I. Espinola, J. A. Camargo, C. A., Jr. Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis. J. Allergy Clin. Immunol., 2012, 130(4), 1007-1008 e1001.
35. Belderbos, M. E. Houben, M. L. Wilbrink, B. Lentjes, E. Bloemen, E. M. Kimpen, J. L. Rovers, M. Bont, L. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics, 2011, 127(6), e1513-1520.
36. Camargo, C. A., Jr. Ingham, T. Wickens, K. Thadhani, R. Silvers, K. M. Epton, M. J. Town, G. I. Pattemore, P. K. Espinola, J. A. Crane, J. New Zealand, A. Allergy Cohort Study, G. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics, 2011, 127(1), e180-e187.
37. Karatekin, G. Kaya, A. Salihoglu, O. Balci, H. Nuhoglu, A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur. J. Clin. Nutr., 2009, 63(4), 473-477.
38. Zosky, G. R. Berry, L. J. Elliot, J. G. James, A. L. Gorman, S. Hart, P. H. Vitamin D deficiency causes deficits in lung function and alters lung structure. Am. J. Respir. Crit. Care Med., 2011, 183(10), 1336-1343.
39. Muhe, L. Lulseged, S. Mason, K. E. Simoes, E. A. F. Case- control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet, 1997, 349(9068), 1801-1804.
40. Wayse, V. Yousafzai, A. Mogale, K. Filteau, S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur. J. Clin. Nutr., 2004, 58(4), 563-567.
41. Roth, D. E. Shah, R. Black, R. E. Baqui, A. H. Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta. Paediatr., 2010, 99(3), 389-393.
42. Roth, D. E. Jones, A. B. Prosser, C. Robinson, J. L. Vohra, S. Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. J. Infect. Dis., 2008, 197(5), 676-680.
43. McNally, J. D. Leis, K. Matheson, L. A. Karuananyake, C. Sankaran, K. Rosenberg, A. M. Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr. Pulmonol., 2009, 44(10), 981-988.
44. Inamo, Y. Hasegawa, M. Saito, K. Hayashi, R. Ishikawa, T. Yoshino, Y. Hashimoto, K. Fuchigami, T. Serum vitamin D concentrations and associated severity of acute lower respiratory tract infections in Japanese hospitalized children. Pediatr. Int., 2011, 53(2), 199-201.
45. Madden, K. Feldman, H. A. Smith, E. M. Gordon, C. M. Keisling, S. M. Sullivan, R. M. Hollis, B. W. Agan, A. A. Randolph, A. G. Vitamin D deficiency in critically ill children. Pediatrics, 2012, 130(3), 421-428.
46. McNally, J. D. Menon, K. Chakraborty, P. Fisher, L. Williams, K. A. Al-Dirbashi, O. Y. Doherty, D. R. Canadian Critical Care Trials, G. The association of vitamin D status with pediatric critical illness. Pediatrics, 2012, 130(3), 429-436.
47. Carter, S. The medicalization of sunlight in the early twentieth century. J. Hist. Sociol., 2012, 25(1), 83-105.
48. Li-Ng, M. Aloia, J. F. Pollack, S. Cunha, B. A. Mikhail, M. Yeh, J. Berbari, N. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol. Infect., 2009, 137(10), 1396-1404.
49. Murdoch, D. R. Slow, S. Chambers, S. T. Jennings, L. C. Stewart, A. W. Priest, P. C. Florkowski, C. M. Livesey, J. H. Camargo, C. A. Scragg, R. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA, 2012, 308(13), 1333-1339.
50. Laaksi, I. Ruohola, J. P. Mattila, V. Auvinen, A. Ylikomi, T. Pihlajamaki, H. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J. Infect. Dis., 2010, 202(5), 809-814.
51. Urashima, M. Segawa, T. Okazaki, M. Kurihara, M. Wada, Y. Ida, H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr., 2010, 91(5), 1255-1260.
52. Camargo, C. A., Jr. Ganmaa, D. Frazier, A. L. Kirchberg, F. F. Stuart, J. J. Kleinman, K. Sumberzul, N. Rich-Edwards, J. W. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics, 2012, 130(3), e561-e567.
53. Charan, J. Goyal, J. P. Saxena, D. Yadav, P., Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis. J. Pharmacol. Pharmacother., 2012, 3(4), 300-303.
54. Martineau, A. R. Timms, P. M. Bothamley, G. H. Hanifa, Y. Islam, K. Claxton, A. P. Packe, G. E. Moore-Gillon, J. C. Darmalingam, M. Davidson, R. N. Milburn, H. J. Baker, L. V. Barker, R. D. Woodward, N. J. Venton, T. R. Barnes, K. E. Mullett, C. J. Coussens, A. K. Rutterford, C. M. Mein, C. A. Davies, G. R. Wilkinson, R. J. Nikolayevskyy, V. Drobniewski, F. A. Eldridge, S. M. Griffiths, C. J. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet, 2011, 377(9761), 242-250.
55. Coussens, A. K. Wilkinson, R. J. Hanifa, Y. Nikolayevskyy, V. Elkington, P. T. Islam, K. Timms, P. M. Venton, T. R. Bothamley, G. H. Packe, G. E. Darmalingam, M. Davidson, R. N. Milburn, H. J. Baker, L. V. Barker, R. D. Mein, C. A. Bhaw-Rosun, L. Nuamah, R. Young, D. B. Drobniewski, F. A. Griffiths, C. J. Martineau, A. R. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc. Natl. Acad. Sci. U. S. A., 2012, 109(38), 15449-15454.
56. Wang, T. J. Zhang, F. Richards, J. B. Kestenbaum, B. van Meurs, J. B. Berry, D. Kiel, D. P. Streeten, E. A. Ohlsson, C. Koller, D. L. Peltonen, L. Cooper, J. D. O'Reilly, P. F. Houston, D. K. Glazer, N. L. Vandenput, L. Peacock, M. Shi, J. Rivadeneira, F. McCarthy, M. I. Anneli, P. de Boer, I. H. Mangino, M. Kato, B. Smyth, D. J. Booth, S. L. Jacques, P. F. Burke, G. L. Goodarzi, M. Cheung, C. L. Wolf, M. Rice, K. Goltzman, D. Hidiroglou, N. Ladouceur, M. Wareham, N. J. Hocking, L. J. Hart, D. Arden, N. K. Cooper, C. Malik, S. Fraser, W. D. Hartikainen, A. L. Zhai, G. Macdonald, H. M. Forouhi, N. G. Loos, R. J. Reid, D. M. Hakim, A. Dennison, E. Liu, Y. Power, C. Stevens, H. E. Jaana, L. Vasan, R. S. Soranzo, N. Bojunga, J. Psaty, B. M. Lorentzon, M. Foroud, T. Harris, T. B. Hofman, A. Jansson, J. O. Cauley, J. A. Uitterlinden, A. G. Gibson, Q. Jarvelin, M. R. Karasik, D. Siscovick, D. S. Econs, M. J. Kritchevsky, S. B. Florez, J. C. Todd, J. A. Dupuis, J. Hypponen, E. Spector, T. D. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet, 2010, 376(9736), 180-188.